Claim Missing Document
Check
Articles

Found 2 Documents
Search

PEMBERDAYAAN MASYARAKAT MELALUI PEMANFAATAN TANAMAN KENIKIR DALAM UPAYA PENCEGAHAN KANKER DI RW16 DAN 17 KELURAHAN CIPAGERAN KECAMATAN CIMAHI UTARA Eem Hayati; Betty Nurhayati; Sonny Feisal Rinaldi
Jurnal Pengabdian Masyarakat Kesehatan Indonesia Vol. 1 No. 1 (2022): Jurnal Pengabdian Masyarakat Kesehatan Indonesia
Publisher : Poltekkes Kemenkes Bandung

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.34011/jpmki.v1i1.971

Abstract

Cancer is a disease that occurs due to the uncontrolled growth of abnormal cells, causing normal body tissues to be damaged. There are several ways that can be done to prevent cancer, including paying attention to and implementing a healthy diet and lifestyle. Some medicinal plants have the potential as anti-cancer that has a cytotoxic effect, one of which is kenikir. Kenikir leaves contain active compounds of alkaloids, polyphenols, saponins, tannins and flavonoid glycosides quercetin. The results of previous studies by several researchers showed that several methanolic extracts from kenikir leaves were known to have a cytotoxic effect on T47D cells and kenikir ethanol extract was proven as an antioxidant and anticancer of the uterus. The purpose of community service is to apply the potential of kenikir leaves as an anti-cancer so that it can be used by the community in RW 16 and 17 Cipageran Village, North Cimahi District. The methods used are counseling to cadres and planting kenikir plant seeds at partner locations. The results of community service obtained that the pre-test and post-test scores in RW 16 were 53 and 93, there was an increase of 76%, while the pre-test and post-test scores in RW 17 were 56 and 88, there was an increase of 57%. The conclusion of the PKM results is that there is an increase in the knowledge and understanding of the cadres regarding the use of kenikir plants in an effort to prevent cancer.  
Comparison of the sigma metrics using the total error allowable algorithm with variation of bias source Sonny Feisal Rinaldi; Anisa Agustia Ibadurrahmah; Surya Ridwanna; Harianto Harianto
JURNAL INDONESIA DARI ILMU LABORATORIUM MEDIS DAN TEKNOLOGI Vol 6 No 1 (2024): Advancements in Biomedical Research: Insights from Medical Laboratory and Technol
Publisher : Universitas Nahdlatul Ulama Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33086/ijmlst.v6i1.4930

Abstract

Sigma Metrics, as a quality indicator, have been widely applied in clinical laboratories to assess the performance of analytical methods. Described in the document Clinical and Laboratory Standards Institute (CLSI) EP15- A3, the use of target values can be sourced from certified reference standards, survey materials from the Proficiency Testing (PT)/External Quality Assessment (EQA), materials used in inter-laboratory quality control programs and internal quality control materials with predetermined targets. This research aims to determine whether there is a difference in the sigma metrics between the bias derived from the manufacturer's target value and those from the peer group source in the External Quality Assurance Services (EQAS) program. The research methodology employed is descriptive comparative analysis, utilizing the results of material inspection data for 15 internal quality control parameters of Clinical Chemistry over a span of 2 years at the Pramita Laboratory in Bandung. The calculation of the sigma metrics commences with computing the coefficient of variation (CV), and the appropriate Total Error aalowable (Tea) sources for each parameter are determined beforehand using the TEa algorithm. The research findings indicate a difference between the sigma metrics derived from the manufacturer's target value and those from the EQAS-peer group target value, accounting for 33% or 10 parameters out of the total parameters with 2 levels of inspection are calculated on the sigma scale. However, in 67% or 20 parameters out of the total parameters, no such difference is observed. Bias associated with the target value from the manufacturer and the EQAS peer group shows no significant difference, suggesting that the laboratory can utilize pre-existing target values confidently.